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Abstract: Urinary incontinence is a medical, psychological, social, economic, and hygienic 
problem. Although it is difficult to state its prevalence, all authors agree that it is related to age 
and gender. This study aimed to carry out a urinary incontinence behavioral treatment in order to 
reduce urine leakages in 14 participants recruited from a senior center. The program consists of 
daily training of the pelvic floor muscles with a weekly control by a supervisor during a 2-month 
period and follow-up of results 2 months after the last control session. Urinary incontinence 
episodes were reduced by 75.67% after program completion. It appears that pelvic floor muscles 
training, carried out under controlled and constant supervision, significantly reduces urinary 
leakage. Moreover, maintaining this improvement after treatment depends on the continuation 
of the exercises as well as on the urinary leakage frequency baseline and the urinary leakage 
frequency during the last treatment session.
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Introduction
Urinary incontinence (UI) represents a very important problem medically, 
psychologically, socially, economically, and hygienically.1,2 People who suffer from UI 
are more likely to have urinary infections, dermatitis, and suffer from falls. Moreover, 
UI may increase isolation, despondency, and depression. Economically, UI involves 
a very high cost. The estimated annual direct average cost of UI per patient in Spain 
is €262. The total direct economic impact of UI on the Spanish national healthcare 
system is €366,687,017.3 Everyday expenditures should also be added to this total, 
such as the increased frequency of clothes washing, the time the family spends taking 
care of the person suffering from UI, and the costs related to the treatment of emotional 
and psychological problems.
In Spain, UI is estimated to affect 10% of women between 25 and 64 years 
old, approximately 5% of men between 50 and 65 years, and more than 50% of 
people .65 years.1,4,5 However, these data are variable because of the differences in 
sample characteristics, the origin of the problem, and the diagnostic criteria used.3,6,7
In Spain, most of the UI cases registered are treated with pharmacological and/or 
surgical therapies or with simple, and usually ineffective, verbal instructions about 
exercising the pelvic floor muscles without any expert supervision.8 These kind of 
interventions fail to resolve the problem and do not reduce the costs caused by the 
complaint.
In terms of treatment effectiveness, a great deal of research shows that pelvic floor 
exercises (Kegel exercises) done in a continuous, constant and controlled manner, are Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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more effective than surgical and pharmacological treatments 
and have fewer secondary effects.9–12 Moreover, these 
positive results are observed for the 3 main types of UI: stress 
UI (involuntary leakage during an effort or exertion because 
of pelvic floor muscle weakness), urge UI (an involuntary 
loss of urine for no apparent reason after suddenly feeling 
the need or urge to urinate due to an overactive bladder), and 
mixed UI (a combination both of the above).7
Therefore, the aim of this study was to build a behavioral 
treatment for feminine UI in order to reduce the involuntary 
urinary leakage in a group of women volunteers from a 
senior center. This treatment program was built on Goode 
et al’s research10 where a standard behavioral treatment was 
implemented based on the execution of Kegel exercises in a 
constant and controlled way. It was also based on research by 
Subak et al13 which studied urinary leakage episodes by the 
implementation of a Kegel exercise treatment in a constant and 
controlled way, but without an exhaustive control of the physi-
cal conditions of the urinary tract, as in the studies by Burgio 
et al and Richter et al.9,14,15 Specifically, the aim of this study 
was to reduce almost 50% of the leakage episodes per week 
by the implementation of such a program and, once the treat-
ment period had finished, performance at least twice a week 
by participants of the exercises as part of their routine.
Methods
Participants
The participants were 14 women volunteers from a senior 
center. They were asked by their sport instructor from the 
senior center to participate in the program. To be included 
in this study, patients had to have had at least 1 incontinent 
episode the week before starting the program. The sample 
characteristics are described in Table 1.
Procedure
This study has a quasi-experimental (“pre-experimental” 
condition) pre–post with only an experimental group design.16 
It is necessary to explain the reasons for the limitations of 
such a design. Originally, 37 women agreed to participate, and 
were to be randomized to 2 groups: experimental and control 
in waiting (who would commence treatment 2 months after 
the first group). In the end, 23 women did not participate in 
the study, however. The reasons given were: 1) 6 women did 
not complete the 9-week program; 2) 7 women did not have 
leakages in the first week of treatment; 3) 3 women were 
taking care of a family member and did not have time to 
participate; 4) 4 women did not have time to participate; and 
5) the remaining 3 women did not give any reason why they 
did not take part in the research. Therefore, all the participants 
became part of the experimental group.
Assessment tools
Two methods to obtain information were used:   structured 
interviews and self-registers. Table 2 summarizes the 
assessment tools used, including the corresponding ref-
erences, what these tools measure, and when they are 
applied.17–20
Intervention
For all subjects, the program consisted of a group information 
session, an individual assessment session, 8-weekly control 
Table 1 Sample characteristics n = 14
Age
  Mean 67
  SD 5.69
  range 60–80
UI type
  Stress 3
  Urge 4
  Mixed 7
Sandvik index (UI severity)
  Light 1
  Moderate 9
  Severe 4
Absorbent pad used
  never 4
  In the street 6
  Always 4
number of children
  Mean 2.07
  SD 1.44
  range 0–6
Weight of the heaviest child
  Mean 3.65
  SD 0.76
  range 2.7–5.3
Mode of delivery
  natural 13
  Cesarean section 1
Disease
  Arthritis 7
  hypertension 2
  Back problems 4
  Parkinson 1
UI associated drugs
  Benzodiazepine 2
  Antidepressants 3
IU impact no Light Moderate
  Physical functioning 12 2 0
  Social activities 13 1 0
  emotional state 8 6 0
  Frustration feelings 10 2 2
Note: *The analysis includes: means, standard deviation, and/or frequencies depending 
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sessions, and a follow-up session two months after the 
  treatment. An expert on this topic developed the whole pro-
gram. The aim of the information session was to introduce 
the program and explain how it worked. The assessment 
sessions lasted 40 minutes and involved a structured inter-
view (Table 2). Furthermore, the participants were asked to 
fill in a self-register to document the time of every void and 
incontinent episode so as to establish the base line (Table 2). 
The control sessions took approximately 15 minutes. In these 
sessions, the supervisor taught the participants how and 
when to do pelvic muscle exercises at home. The subjects 
were asked to do these exercises 3 times a day in 3 different 
positions: lying, sitting, and standing. Every 2 weeks, the 
supervisor gave the participants new guidelines on the length 
and the number of contractions and relaxations. Each week, 
participants were asked to fill out self-registers on leakages 
and exercises. Moreover, they were praised for bringing back 
the self-register well completed and all problems or doubts 
that arose during the previous week were clarified.
After 2 weeks of treatment, when pelvic muscles had 
become stronger and the exercise regime was set up, par-
ticipants were encouraged to contract pelvic muscles during 
activities that commonly resulted in incontinence. For stress 
UI, they were instructed to contract pelvic muscles when 
making an effort like sneezing, laughing, or running. The con-
tractions were to be performed at the time of the effort or just 
before it in order to make the relation between the effort and 
the pelvic muscles contraction stronger. For urge UI, instead 
of running to void as soon as they suddenly felt the urge to 
urinate (which, in turn, raises bladder pressure and increases 
the chances of leakages), participants were told to sit down 
(if possible), relax, and contract pelvic muscles repeatedly 
to reduce the urgency and the detrusor muscle contraction. 
They were to try not to void until the urge disappeared, after 
which they should urinate normally.
Two months after the last control session, the participants 
were summoned to the follow-up session. In this session, 
people were asked about their progress on the continuity of 
exercises, their incontinence episodes, and the frequency of 
leakage, if appropriate. Finally, participants were asked to 
fill in a self-register about the frequency of exercises and 
leakages during the following week.
Results
Descriptive data analysis was performed on the data 
collected in the structured interview in order to describe the 
sample (see Table 1). Correlations were studied to analyze 
associations between UI and theory-related variables. 
Repeated measures analyses of variance were performed to 
analyze treatment effects. Finally, an independent-sample 
t-test was carried out to gauge the differences between the 
mean leakages, depending on maintaining or stopping the 
exercises after the treatment.21
The application of the treatment program has had positive 
results, even though the interpretation of these results must 
be cautious due to the weakness of the experimental design 
(no control group and a small sample size).
Firstly, some variable associations must be emphasized. 
On one hand, self-reported UI severity (Sandvik index) cor-
relates (r = 0.761; P = 0.002) with real UI severity (number 
of leakages in the base line). On the other hand, the more 
drugs taken, the more self-reported UI severity (r = 0.643; 
P = 0.013) and the more real UI severity the participants had 
(r = 0.716; P = 0.004).18
For the controlled treatment and the follow-up results, 
Figure 1 shows that there is an important decrease in the mean 
Table 2 Assessment tools
Tool References What assessments? Application moment
Assessment structured interview  Uebersax et al17  UI type  At the beginning of the program
 Klovning18  UI severity
 Fernández-Ballesteros et al19  Associated diseases
 UI impact
 general health
Leakage self-registered  Verdejo20  Leakage/day 
 Voiding frequency
 evaluation week 
 every treatment week
exercises self-registered  exercises control  every treatment week
Follow-up structured interview    exercises continuity after  
the treatment
 Follow-up week
 exercises frequency
Follow-up self-registered  Leakage/day 
 exercises/day
 Follow-up weekClinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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leakage between the pretreatment week and the post-treatment 
week and a slight increase in the follow-up week.
In order to see if the decrease in incontinence was 
significant after the intervention program, a repeated 
measure analysis of variance was performed. Multivariate 
contrasts show that the null hypothesis of equal means 
can be rejected (F = 7.512; P = 0.008) and the sphericity 
hypothesis cannot be rejected (W = 0.994; P # 0.965). 
Therefore, the variances–covariances matrix can be assumed 
to be spherical. Consequently, an unvaried approximation 
(sphericity assumed) is used, null hypothesis of equal means 
can be rejected, and it can be concluded that mean leakages 
before, after, and at the 2-month follow-up are not the same 
(F = 8.732; P = 0.001).
In the polynomial contrast test, the null hypothesis of 
lineal components (F = 11.036; P = 0.005) and quadratic 
components (F = 6.167; P = 0.027) are rejected. As there 
are 2 significant components, the one with the higher level 
is considered to be better fitted, as Figure 1 shows.
The mean leakage in the baseline correlates with the 
difference between the mean leakage in the pretreatment 
and post-treatment weeks (r = 0.911 P = 0.000). This means 
that the more leakages occurring at the baseline, the greater 
the decrease. A ground effect exists for the post-treatment 
week, in which most of the sample had a very low leakage 
level, hence the pretreatment mean leakage does not correlate 
with the post-treatment mean leakage (r = 0.453; P = 0.104). 
Nevertheless, the baseline mean leakage correlates with mean 
leakage for the follow-up week (r = 0.539; P = 0.047), which 
means that the greater the baseline mean leakage, the greater 
the leakage in the follow-up.
Table 3 shows that women who managed not to 
experience any urine loss had a significantly lower baseline 
leakage and leakage in the follow-up week than those who 
were not able to stop the leakeges.
 In the follow-up session, while 7 women reported to 
have continued doing the pelvic muscle exercises after the 
treatment, the other 7 reported having stopped them.
We have found that 6 out of 7 women who continued 
to do the exercises every day maintained the same leakage 
frequency in the follow-up week as in the last control session 
(mostly, few or no urine losses). Moreover, of the 7 women 
who did not continue to do the exercises, 4 suffered a relapse 
and three improved.
An independent-sample t-test was performed to gauge 
the differences between the mean leakages depending on 
continuation or halting of the exercises after the treatment. 
Equal variances have been assumed, as Levene test pointed 
out, for the 3 variables analyzed. We discovered that the 
women who continued doing daily exercises after the treat-
ment had a significantly lower baseline leakage than those 
who ceased the exercises (F = 14.511; P = 0.002). Moreover, 
they did not experience leakages in the post-treatment week 
(F = 18.834; P = 0.001), and they had a significantly lower 
mean leakage in the follow-up week (F = 4.9591; P = 0.046) 
(Figures 2 and 3).
Discussion
This study aimed to carry out a UI behavioral treatment 
in order to reduce the urine leakage by using pelvic floor 
exercises in volunteer participants from a senior center.
The results show that urge, stress, and mixed UI can be 
significantly reduced by completing a standard intervention 
program, consisting of Kegel exercises, as other authors 
have already proposed.9,14,22,23 The women showed a 75.67% 
mean reduction, which is approximately the same as shown 
in data from other studies.14 Moreover, it seems that these 
results continue over time or, at least, it takes time to return 
to the initial situation, if women continue doing pelvic floor 
exercises. It would be interesting to carry out more follow-up 
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Figure 1 Development of leakages (mean values at each time point).
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Table 3 Independent-sample test
Leakage  
“post-treatment”
N M SD F Sig.
Leakage  
“pre-treatment”
$1
0
6
8
10.67
2.50
4.50
2.00
6.44 0.026
Leakage  
“follow-up”
$1
0
6
8
4.17
0.25
5.19
0.71
6.56 0.025Clinical Interventions in Aging 2011:6 submit your manuscript | www.dovepress.com
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measurements in order to gather more information about how 
the habit of doing daily pelvic floor exercises (or not) and 
UI relate to each other.
Moreover, as Subak et al have already pointed out, the 
physical conditions of the urinary tract do not necessarily 
have to be exhaustively assessed.13 In this study, the 
incontinence episodes were reduced after doing pelvic floor 
exercises, even if the potential interfering variables were 
not taken into account. These results occurred despite the 
drugs taken (benzodiazepines, antidepressants, or diuretics) 
or the diseases suffered (diabetes, fecal incontinence), which 
would normally have excluded these participants from other 
studies.9,13,14 These risk factors were not frequent in this 
sample, however.
For the risk factors that reduce pelvic floor exercise 
effectiveness, Richter et al related treatment success 
to fewer incontinence episodes in the baseline, less 
use of absorbents, no UI surgery intervention, and low 
  educational level. In this study, we found a relationship 
between the number of baseline leakages and those in 
the follow-up week.9 This would mean that, because 
all the participants had nearly zero leakages by the end of 
the treatment, the greater the number of urinary leakage 
episodes at the beginning of the treatment, the greater 
the difficulty maintaining positive results after treatment. 
Moreover, relationships between the number of drugs 
taken and real (r = 0.643; P = 0.013) and self-reported 
(r = 0.716; P = 0.004) severity have been found. This 
aforementioned relationship has already been pointed out 
by Holroyd-Leduc et al.23
Our study confirms the effectiveness of Kegel exercises, 
although treatment adherence must be taken into account. 
Every participant knew about Kegel exercises and their 
benefits, because their doctors had explained these to them, 
yet they did not perform them. This confirms the importance 
of having expert supervision (at least, at the beginning) 
which guarantees the acquisition of the new habit and 
demonstrates the changes that can occur. On this theme, 
Burgio et al proposed a research study where the aim was 
to compare the results between a self-administered Kegel 
exercise treatment and an identical one that was controlled 
by an expert.14 The study showed that the control group 
had significantly less incontinence episodes than the self-
administered one.
Getting women into the habit of performing daily pelvic 
floor exercises was a secondary aim of this study. Half of the 
sample continued doing daily exercises while the other half 
continued the exercises just once or twice a week. Women 
who continued to do daily exercises also had a lower baseline 
leakage, no leakage at the end of the treatment, and less in 
the follow-up. This makes the interpretation of data com-
plicated, because of the presence of two variables: number 
of leakages per week (in base line, last treatment week, 
and follow-up week) and exercise continuity. According to 
these results, during the treatment period every participant 
strengthened their pelvic muscles (observed by the reduction 
in leakages). However, the strength level was not the same for 
everyone. While some women completely stopped leakages 
from the first week, others did not attain this result until the 
end. Therefore, although the sample had a very low leakage 
level, some continued having leakages and these participants 
were the ones who did not continue to do the exercises after 
the treatment. A possible explanation for this could be that 
women who continued having incontinence episodes in the 
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last treatment week were not motivated enough to continue 
doing the exercises after the treatment, even though they 
had experienced a leakage reduction. According to this 
result, the duration of the treatment (the time of controlled 
administration) should depend on the UI severity, and expert 
control should not be removed until the person had a fixed 
regime and had obtained consolidated results.
In future studies, we propose analyzing the success of 
the behavioral treatment depending on the UI severity, and 
controlling the length and frequency of the control and the 
intensity of the treatment (number of exercises per day), as 
these are potentially interesting variables.
In spite of the design weakness, the method and results 
are in accordance with previous studies.14 Enhancing this 
type of treatment is very important because it is effective, 
has no side effects, and is not intrusive. In fact, in our study, 
the whole sample reduced their incontinence episodes, 
regardless of the UI type, the UI severity, and their health 
characteristics.
In summary, UI is a problem with bio-psychosocial 
consequences, which can be eliminated or reduced by per-
forming Kegel exercises, even without having an exhaus-
tive control of urinary tract variables. Expert supervision 
guarantees the efficacy of the treatment in the short and 
long term.
Conclusion
•  Adherence to the behavioral UI treatment reduces leakage 
episodes without having an exhaustive control of urinary 
tract variables.
•  In order to get treatment adherence, it is necessary to have 
expert supervision which guarantees that the exercises 
are being performed correctly and frequently.
•  It is important to continue studying potentially influential 
variables that increase or reduce UI treatment – not only 
the variables of the individual but also the treatment 
variables.
Therefore, this study, in a modest way, contributes to UI 
treatment and aims to enhance the importance of transmit-
ting real information about UI, such as the fact that UI is a 
problem that is not inherent to age,24 that it can be dealt with 
by behavioral treatments, and that absorbents are only pallia-
tive methods which, far from solving the problem, increase 
the likelihood of leakages.25
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